These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1388704)

  • 1. A critical review of the toxicology of glutaraldehyde.
    Beauchamp RO; St Clair MB; Fennell TR; Clarke DO; Morgan KT; Kari FW
    Crit Rev Toxicol; 1992; 22(3-4):143-74. PubMed ID: 1388704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acute toxicity and primary irritancy of glutaraldehyde solutions.
    Ballantyne B; Myers RC
    Vet Hum Toxicol; 2001 Aug; 43(4):193-202. PubMed ID: 11474730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin and respiratory symptoms from exposure to alkaline glutaraldehyde in medical services.
    Norbäck D
    Scand J Work Environ Health; 1988 Dec; 14(6):366-71. PubMed ID: 2975045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety assessment of poloxamers 101, 105, 108, 122, 123, 124, 181, 182, 183, 184, 185, 188, 212, 215, 217, 231, 234, 235, 237, 238, 282, 284, 288, 331, 333, 334, 335, 338, 401, 402, 403, and 407, poloxamer 105 benzoate, and poloxamer 182 dibenzoate as used in cosmetics.
    Singh-Joy SD; McLain VC
    Int J Toxicol; 2008; 27 Suppl 2():93-128. PubMed ID: 18830866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaraldehyde: the two-percent solution.
    Hosp Hazard Mater Manage; 1989 Nov; 3(2):4-7. PubMed ID: 10313488
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preliminary assessment of occupational exposure to Glutaraldehyde in selected endoscopic workplaces].
    Małaszuk J; Andrzejak R; Przybylski M; Jurga M; Szymańska A; Leszczyszyn J
    Med Pr; 2000; 51(4):365-71. PubMed ID: 11059410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics.
    Int J Toxicol; 2005; 24 Suppl 2():21-50. PubMed ID: 16154914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Glutaraldehyde (CAS NO. 111-30-8) in F344/N Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Sep; 490():1-234. PubMed ID: 12563341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutaraldehyde overexposure: myth or reality? One hospital-wide study.
    Notarianni GL
    J Healthc Mater Manage; 1992 Jul; 10(6):20, 22, 24 passim. PubMed ID: 10119229
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptoms and lung function in health care personnel exposed to glutaraldehyde.
    Waters A; Beach J; Abramson M
    Am J Ind Med; 2003 Feb; 43(2):196-203. PubMed ID: 12541275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recommended occupational exposure limit for formaldehyde based on irritation.
    Paustenbach D; Alarie Y; Kulle T; Schachter N; Smith R; Swenberg J; Witschi H; Horowitz SB
    J Toxicol Environ Health; 1997 Feb; 50(3):217-63. PubMed ID: 9055874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trinitrotoluene: a review of reported dose-related effects providing documentation for a workplace standard.
    Hathaway JA
    J Occup Med; 1977 May; 19(5):341-5. PubMed ID: 140930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity studies of Glutaraldehyde (CAS No. 111-30-8) Adminstered by Inhalation to F344/N Rats and B6C3F1 Mice.
    Kari F
    Toxic Rep Ser; 1993 Mar; 25():1-E10. PubMed ID: 12209181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic analysis of F344 rat nasal epithelium suggests that the lack of carcinogenic response to glutaraldehyde is due to its greater toxicity compared to formaldehyde.
    Hester SD; Barry WT; Zou F; Wolf DC
    Toxicol Pathol; 2005; 33(4):415-24. PubMed ID: 16036858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Working with glutaraldehyde.
    Worthington K
    Am J Nurs; 2001 Jun; 101(6):88. PubMed ID: 11441767
    [No Abstract]   [Full Text] [Related]  

  • 19. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
    McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
    Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaraldehyde: a potential health risk to nurses.
    Newman MA; Kachuba JB
    Gastroenterol Nurs; 1992 Jun; 14(6):296-300, discussion 300-1. PubMed ID: 1623031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.